Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy

Martínez-Campreciós, Joan; Riveiro-Barciela, Mar; Muñoz-Gómez, Raquel; Londoño, María-Carlota; Roget, Mercé; Serra, Miguel Ángel; Escudero-García, Desamparados; Purchades, Laura; Rodríguez, Manuel; Losa-García, Juan E.
Gastroenterol. hepatol. (Ed. impr.) ; 46(8): 594-602, oct. 2023. tab, graf
Artículo en Inglés | IBECS (España) | ID: ibc-225937

Documentos relacionados

  1. Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy.
  2. Hepatitis C treatment in patients with kidney disease.
  3. Effects of oral alkali drug therapy on clinical outcomes in pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis.
  4. Add-on neurological benefits of antiviral therapy in HCV patients with chronic kidney disease - a nationwide cohort study.
  5. Interventions for dialysis patients with hepatitis C virus (HCV) infection.
  6. Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.
  7. Mortality of Patients on Maintenance Hemodialysis Submitted to Coronary Artery Bypass Surgery.
  8. Change in estimated glomerular filtration rate and outcomes in chronic kidney disease.
  9. The effect of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use on mortality in patients with chronic kidney disease: a meta-analysis of observational studies.
  10. Allopurinol Initiation and All-Cause Mortality Among Patients With Gout and Concurrent Chronic Kidney Disease : A Population-Based Cohort Study.